Solara Active Pharma Sciences Ltd, a leading manufacturer of Active Pharmaceutical Ingredients (APIs) and Contract Research and Manufacturing Services (CRAMS), unveiled the details of its upcoming rights issue on May 09, 2024. This strategic initiative aims to raise ₹449.95 crore to fuel the company’s continued growth and expansion plans. Attractive Offer for Existing Shareholders The …